Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136182 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Pelin Ergun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Transcriptome, Sulfonamides, Pepsin A, Carbamates. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wisconsin Department of Otolaryngology and Communication Sciences.
Abstract (Originalsprache)
Gastroesophageal reflux disease (GERD) is associated with inflammatory and neoplastic changes in the esophageal epithelium. Despite widespread PPI use, esophageal adenocarcinoma (EAC) incidence continues to rise, implicating non-acidic reflux components such as pepsin in disease progression. We performed transcriptomic profiling to assess pepsin-induced changes and the protective effect of amprenavir in vitro. Het-1A (normal) and BAR-T (Barrett’s) cells (n = 3) were treated at pH 7.0 with pepsin and/or 10 μM amprenavir for 1 h. RNA-seq identified DEGs (FDR ≤ 0.05, |log₂FC| ≥ 0.375), and Ingenuity Pathway Analysis revealed enriched pathways. Pepsin exposure altered mitochondrial function, oxidative phosphorylation, epithelial integrity, signaling, and inflammatory pathways in both cell lines. Amprenavir attenuated these transcriptomic perturbations, preserving mitochondrial and stress-response pathways. Notably, BAR-T cells exhibited heightened activation of wound-healing and epithelial repair pathways, whereas Het-1A cells showed greater mitochondrial and systemic stress pathway alterations. Pepsin drives transcriptomic dysregulation in esophageal epithelial cells under non-acidic conditions, and amprenavir shows potential to counteract peptic injury. Further studies are needed to validate these findings and explore amprenavir’s therapeutic utility in GERD management and EAC prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Mellowes Center for Genomic Science and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Division of Biostatistics, Data Science Institute, MCW Cancer Center and Mellowes Center for Genome Science and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
ORCID-Profile: Pelin Ergun, Tina L Samuels, Angela J Mathison, Victor X Jin
Förderung
- Wisconsin Department of Otolaryngology and Communication Sciences
Zitieren
APA
Ergun, P., Samuels, T. L., Mathison, A. J., Liu, T., Jin, V. X., & Johnston, N. (2025). Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136182
Vancouver
Ergun P, Samuels TL, Mathison AJ, Liu T, Jin VX, Johnston N. Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136182
BibTeX
@article{Ergun2025,
author = {Ergun, Pelin and Samuels, Tina L and Mathison, Angela J and Liu, Tianxiang and Jin, Victor X and Johnston, Nikki},
title = {Amprenavir Mitigates Pepsin-Induced Transcriptomic Changes in Normal and Precancerous Esophageal Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136182}
}
EUVIMED